Order Article Reprints

Daniels H, Hassan M, Babiker O, Rowley W, Qaisar A, Phillips E, Griffin E, Bell C, Baraka B, Acharige S, et al. UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme. Cancers. 2025; 17(17):2732. https://doi.org/10.3390/cancers17172732

Daniels, Harry, Mona Hassan, Omer Babiker, William Rowley, Aitzaz Qaisar, Emma Phillips, Ellana Griffin, Catherine Bell, Bahaaeldin Baraka, Shyamika Acharige, and et al. 2025. "UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme" Cancers 17, no. 17: 2732. https://doi.org/10.3390/cancers17172732

Daniels, H., Hassan, M., Babiker, O., Rowley, W., Qaisar, A., Phillips, E., Griffin, E., Bell, C., Baraka, B., Acharige, S., Aquino, M., Plant, R., Mencel, J., Chan, S., Parslow, D., Arora, A., Scott-Brown, M., Khakoo, S., Braconi, C., ... Sivakumar, S. (2025). UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme. Cancers, 17(17), 2732. https://doi.org/10.3390/cancers17172732